NEU 3.50% $14.05 neuren pharmaceuticals limited

Acadia, page-262

  1. 2,211 Posts.
    lightbulb Created with Sketch. 326
    The basis for the rebound in SP for Acadia comes from the "DAYBUE" sales Roll out. I expect this to continue and increase as DAYBUE patient number increases. Revenue is king.
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.